Appalachian State University Human Performance Lab, North Carolina Research Campus
Kannapolis, North Carolina, 28081, United States
NCT Number: NCT03041077
Joint discomfort is reported by 32% of U.S. adults, and increases with age. The knee is the most common site of joint discomfort regardless of age. Nearly half of people with knee joint discomfort use natural supplements to alleviate symptoms, but more research is needed to determine their effectiveness. In a previous study, we measured the effect of 8-weeks ingestion of a commercialized joint support dietary supplement (InstaflexTM Joint Support, Direct Digital, Charlotte, NC) compared to placebo on joint discomfort, stiffness, and function in adults with self-reported joint discomfort. This study will be repeated using Instaflex Advanced, with a longer 12-week time period. The Instaflex Advanced supplement includes six products: turmeric, resveratrol, Boswellia serrata, collagen, hyaluronic acid, and black pepper extract. This unique blend may improve joint function and increase mobility, but has not yet been tested in humans using a randomized, double-blinded, placebo-controlled research design. The primary purpose of this study is to assess the effect of 12-weeks ingestion of the Instaflex Advanced supplement compared to placebo in improving knee function in adults with self-reported knee joint discomfort.
Looking for future studies?
Notify Me50 year–75 year
All sexes
Interventional
Not applicable
Kannapolis, North Carolina, 28081, United States
The research procedures will be conducted at the Human Performance Laboratory (Room 1201, Plants for Human Health Institute Building, 600 Laureate Way), operated by Appalachian State University at the North Carolina Research Campus (NCRC) in Kannapolis, NC. Subjects will come here for orientation/baseline testing and then 3 other lab visits (each session will take about 30 minutes). The total amount of time study participants will be asked to volunteer for this study is about 2 hours at the Human Performance Laboratory (over a 12-week period). Participants will also take a daily supplement for 12 weeks and keep compliant with this regimen.
Lab visit testing sequence:
Supplements:
Supplements (Instaflex Advanced, placebo) will be contained in identical looking capsules and organized by day of the week in supplement organizer trays. Study participants will take 1 capsule each day in the morning. The placebo capsules contain magnesium stearate, an inert substance. The Instaflex Advanced supplement ingredients include: turmeric, resveratrol, Boswellia serrata, collagen, hyaluronic acid, and black pepper extract. Compliance will be monitored with bi-weekly email messages, and by counting unused capsules when the supplement trays every 4 weeks. Acetaminophen, as found in Tylenol, will be allowed as a rescue medicine for pain during the study as needed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Joint function
Placebo
Time frame: Change from baseline WOMAC total score at 4 weeks, 8 weeks, 12 weeks
WOMAC questionnaire responses pre-study, 4 weeks, 8 weeks, 12 weeks
Time frame: Change from baseline WOMAC subscales at 4 weeks, 8 weeks, 12 weeks
WOMAC questionnaire subscale responses pre-study, 4 weeks, 8 weeks, 12 weeks
Time frame: Change from baseline visual pain scale at 4 weeks, 8 weeks, 12 weeks
10-point Likert-type scale for knee pain severity
Time frame: Change from baseline POMS at 4 weeks, 8 weeks, 12 weeks
Assessment of mood state
Time frame: Change from baseline 6 minute walk test at 4 weeks, 8 weeks, 12 weeks
Maximum distance covered during 6 minutes of walking
Appalachian State University
Other
Influence of Instaflex Advanced Supplement on Joint Function: A Randomized, Placebo-controlled Community Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07438561
Behavior, Knee Discomfort
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05975879
Arthritis, Joint Diseases
Kazan', Russia
View Trial DetailsNCT04506411
Arthralgia, Joint Diseases
Zagreb, Croatia
View Trial DetailsNCT05347602
Arthritis, Arthritis, Rheumatoid
St Louis, Missouri, United States
View Trial Details